EGFR

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

EGFR
Sep 6, 2024, 15:44 | Insight
Jerónimo Rafael Rodríguez Cid: EGFR mutated patients doesnt have any benefit with immunotherapy in TKI's resistant tumors
Jerónimo Rafael Rodríguez Cid, Medical Oncologist in CDMX, shared a post on X: "We published…
Sep 1, 2024, 09:48 | Insight
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Jarushka Naidoo shared a post on X: "Phase  III Keynote-789 Trial of Platinum + Pemetrexed +/-Pembro…
Aug 28, 2024, 19:52 | Blog
Impact of baseline positive vs negative plasma Circulating tumor DNA for Estimated glomerular filtration rate in the FLAURA2 trial by Jonathan Riess
David Gandara, Co-Director-Center for Experimental Therapeutics, shared a post on X: "At Cal Cancer Consortium…
Aug 28, 2024, 17:09 | Blog
Tanja Obradovic: Importance of vigilant toxicity monitoring
Tanja Obradovic shared a post on LinkedIn: "Importance of vigilant toxicity monitoring as well as early…
Aug 27, 2024, 22:13 | Insight
Stephen Liu: Final anaysis of WJOG9717L
Stephen Liu shared a post on X: “Final anaysis of WJOG9717L (phase II osimertinib +/-…
Aug 27, 2024, 21:52 | Blog
David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA
David Gandara, Co-Director-Center for Experimental Therapeutics at UC Davis Comprehensive Cancer Center, shared a post…
Aug 16, 2024, 12:23 | Societies
Hidehito Horinouchi summarizes some abstracts of WCLC24
Hidehito Horinouchi shared on X: Antibody Drug Conjugates in SCLC by Charlie Rudin Ifinatamab Deruxtecan…
Aug 14, 2024, 13:49 | Insight
Amol Akhade: New and exciting data coming up at WLCC 24
Amol Akhade shared on X about recent papers: "What's new and exciting data coming up…
Aug 13, 2024, 11:55 | Blog
Katsuaki Maehara: Uncommon EGFR Mutations and the variability in therapeutic efficacy
Katsuaki Maehara, Director of Medical Education Colleagues shared a post on X: "Uncommon EGFR mutations…
Aug 13, 2024, 09:57 | Blog
Zosia Piotrowska about what's next for EGFR at DCLung24
Stephen V Liu posted on X: "Dr. Zosia Piotrowska from MGH Thoracic Oncology will discuss…
Aug 12, 2024, 16:45 | Blog
Chul Kim on the advances in treating lung cancer with exon 20 or mutation at DCLung24
Stephen V Liu shared on X: "Dr. Chul Kim will discuss advances in treating lung…
Aug 12, 2024, 11:14 | Insight
Narjust Florez: Abstracts for our Presidential Symposium 2 at WCLC24
Narjust Florez shared a post on X: “Check out these abstracts for our Presidential Symposium…
Aug 11, 2024, 19:47 | Blog
Praveen Kumar Marimuthu: Phase 2 trial Carboplatin, Pemetrexed, Cetuximab for advanced NSCLC
Praveen Kumar Marimuthu, Final year Medical Oncology Trainee at CMC Vellore, shared on X: "OPEN FOR…
Aug 10, 2024, 13:45 | Insight
Katsuaki Maehara: EGFR mutated NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues shared a post on X: “EGFR mutated NSCLC.…
Aug 8, 2024, 02:34 | Blog
Dr. Isabel Preeshagul will discuss perioperative targeted therapy for lung cancer at DCLung24
Stephen V Liu shared on X: “Dr. Isabel Preeshagul will discuss perioperative targeted therapy for…
Aug 6, 2024, 01:06 | Insight
Metastatic lung adenocarcinoma with EGFR and TP53 co-mutations shows mixed intra-patient tumor responses
Yüksel Ürün shared on X: "Metastatic lung adenocarcinoma with Epidermal Growth Factor Receptor (EGFR) and…
Aug 5, 2024, 14:12 | Insight
‘Meet the Expert’ session with oncology dietician Melissa Gaunt - EGFR Positive UK
EGFR Positive UK shared on X: “Eating well with EGFR positive lung cancer is so important.…
Aug 1, 2024, 15:21 | Blog
Denis Horgan: Unfortunate situation severely hampers European Union’s efforts to combat cancer
Denis Horgan, Chair at Independent Advisory Committee Chair, ICGC ARGO,  shared a post on Linkedin…
Jul 30, 2024, 01:45 | Insight
TKIs with vs without upfront SRS for EGFR+ and ALK+ NSCLC and brain metastasis
Biagio Ricciuti shared on X about a recent paper by Luke Pike et al. titled…
Jul 25, 2024, 21:48 | Insight
Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?
Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…
Jul 25, 2024, 21:45 | Insight
Angela Mastronuzzi: Gliomatosis cerebri in children
Angela Mastronuzzi shared on LinkedIn a recent paper by Gunther Nussbaumer et al. titled "Gliomatosis…
Jul 25, 2024, 14:02 | Insight
Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?
Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…
Jul 23, 2024, 00:16 | Blog
Research brings hope, advancing Glioblastoma treatments - Mayo Clinic
Mayo Clinic’s shared a post on LinkedIn: “Globally, approximately 300,000 people are diagnosed each year…
Jul 11, 2024, 06:37 | Insight
Results of the Complete Review on Targeted Therapies for Advanced Urothelial Carcinoma
María Natalia Gandur Quiroga shared on X: " Results and Main Messages of the Complete…
Jul 10, 2024, 09:39 | Blog
Jerónimo Rafael Rodríguez Cid: A secondary analysis from MARIPOSA
Jerónimo Rafael Rodríguez Cid, Medical Oncologist at CDMX shared a post on X: “We published…
Jul 10, 2024, 01:12 | Blog
Cancer History Project - Highlights from Lung Cancer SPORE Workshop
Cancer History Project shared on X: " Yale Cancer Center hosted the annual Lung Cancer SPORE…
Jul 8, 2024, 13:11 | Blog
New EGFR+ UK 2024 Survey Insights
EGFR Positive UK shared on X: “New EGFR+ UK 2024 Survey Insights Only 49% said…
Jul 8, 2024, 03:27 | Blog
Timely genomic testing for lung cancer - EGFR Positive UK
EGFR Positive UK shared on X: "EGFR and ROS-1 co-occurrence in lung cancer may be…
Jul 5, 2024, 06:54 | Blog
Estela Rodriguez: Underreported toxicity of myopathy from EGFR TKIs
Estela Rodriguez shared a post by Stephen V Liu, on X: "Important to study under reported toxicity…
Jul 3, 2024, 23:31 | Blog
A few papers to read about Precision oncology and use of AI suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah: "1. In advanced prostate cancer, deep learning…
Jun 29, 2024, 07:45 | Insight
Katsuaki Maehara: The changes in TME and TKI treatment resistance by EGFR and ALK TKI
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:       …
Jun 26, 2024, 12:40 | Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 25, 2024, 13:50 | Blog
Roy Herbst: Thrilled to host the lung interspore meeting
Roy Herbst, Chief of Medical Oncology at Yale University, shared a post on X:  "Thrilled…
Jun 23, 2024, 10:44 | Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
Jun 22, 2024, 03:29 | Insight
Triparna Sen: Celebrating 20 years of EGFR
Triparna Sen, Associate Professor at Icahn School of Medicine at Mount Sinai, posted on X: “Had…
Jun 21, 2024, 13:43 | Insight
Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy
Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…
Jun 16, 2024, 12:44 | Insight
Mara Antonoff: Dr Heather Wakelee clarifies the role of chemotherapy in NSCLC
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, shared on…
Jun 14, 2024, 03:39 | Societies
Fred R. Hirsch: Great opening of Lung SPORE meeting
Fred R. Hirsch, Director at the Center for Thoracic Oncology at Mount Sinai Hospital, shared…
Jun 13, 2024, 15:48 | Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 10, 2024, 09:53 | Blog
We are proud to be members of Lung Cancer Europe - Oncogene Cancer Research
Oncogene Cancer Research recently shared a post by Lung Cancer Europe on LinkedIn, adding: "We…
Jun 1, 2024, 21:10 | Blog
LUNGevity Foundation - Subcutan injection or IV infusion for EGFR + NSCLC
LUNGevity Foundation shared a post on X: "Subcutan injection or IV infusion? Does it matter? Phas…
May 30, 2024, 11:55 | Blog
Pankaj Kumar Panda: Enriching interactive MTB webinar on First line management of EGFR mutated NSCLC
Pankaj Kumar Panda, Clinical Researcher at National Cancer Centre Singapore, shared a post on X: "Join…
May 29, 2024, 09:22 | Blog
Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"
Eric K. Singhi reshared his previous post on X and added:       ; "But…
May 29, 2024, 04:59 | Blog
Estela Rodriguez: Patients excluded from most clinical trials does not help us find solutions with Leptomeningeal disease
Estela Rodriguez shared a post by EGFR Resisters on X/Twitter: "Leptomeningeal disease - is one of…
May 24, 2024, 14:15 | Blog
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X: “Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the…
May 20, 2024, 07:20 | Insight
Florez Lab: ACS Journal Cancer highlights the Florez Lab's Pregnancy and Lung Cancer Registry
Florez Lab shared a post by ACS Journal Cancer, on X "Thank you to ACS…
May 19, 2024, 14:53 | Insight
Sergio Cifuentes Canaval: KN 189 and 407 - Pooled Analysis of Outcomes
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared on LinkedIn: "KN 189…
May 19, 2024, 05:29 | Blog
Eric Singhi: With FLAURAishing new frontline combination therapies for EGFR and metastatic NSCLC yet incomplete data
Eric Singhi shared on X: "With FLAURAishing new frontline combination therapies for EGFR and metastatic…
May 16, 2024, 16:51 | Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 14, 2024, 16:28 | Blog
Christian Rolfo: Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR
Christian Rolfo, Associate Director Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute…
Apr 22, 2024, 13:13 | Blog
Fantastic to have our Co-founders Yvonne Diaz and Jan Clark attend BTOG24 in Belfast this week - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn:  “Fantastic to have our Co-founders Yvonne Diaz…
Apr 21, 2024, 21:21 | Insight
Mainak Bardhan: Miami Cancer Institute Research Precision Oncology symposium 2nd Annual at The Ritz Carlton spearhead by one and only Manmeet Ahluwalia
Mainak Bardhan, Chief Scientific Officer, Chief of Medical Oncology and Deputy Director of Miami Cancer Institute,…
Apr 16, 2024, 20:18 | Blog
Save the Date for the 4th Annual “Living with EGFR-Mutant Lung Cancer” forum! - Dana Farber's EGFR-Mutant Lung Cancer Center
Quoting Dana Farber's EGFR-Mutant Lung Cancer Center on X/Twitter: "Save the Date: Register today for…
Apr 10, 2024, 08:56 | Career
Pasi Jänne was recently recognised with the ACS 2024 Medal of Honour Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Pasi Jänne, senior vice president for Translational…
Mar 31, 2024, 08:44 | Blog
UCLA Health Jonsson Comprehensive Cancer Center's presentation at the annual meeting of the American Association for Cancer Research (AACR)
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
Mar 26, 2024, 00:22 | Opinion
Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants
Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…
Mar 4, 2024, 17:34 | Insight
Jill Feldman: The importance of focusing on the 3 P's when discussing treatment options after a patient experiences progression on targeted therapy
Jill Feldman, Co-Founder of EGFR Resisters, posted on LinkedIn: "It was an honor to collaborate…
Jan 16, 2024, 05:48 | Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 8, 2024, 14:37 | Blog
A 32-year-old lung cancer survivor, mother of 2 and oncology nurse practitioner - EGFR Resisters
EGFR Resisters shared a post on X/Twitter: "Meet Caroline, A 32-year-old lung cancer survivor, mother…
Sep 28, 2023, 19:02 | Blog
Joel Bervell: Messages like this are my reminder of how important it is to create content about healthcare disparities and how powerful spreading accurate information via social media can be.
May 14, 2023, 09:34 | Drugs
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions - The ASCO Post
Quoting from ASCO Post, "Amivantamab-vmjw, an EGFR and MET bispecific monoclonal antibody, has demonstrated encouraging…
All: 61 Posts: 1 - 100
Special Coverage